NCT00080275View on ClinicalTrials.gov

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

March 31, 2004

Conditions
Hypercholesterolemia
Interventions
DRUG

Niacin Extended-Release and simvastatin Tablets

Sponsors
All Listed Sponsors
lead

Kos Pharmaceuticals

INDUSTRY